Assembly Biosciences Stock Price on January 3, 2025
| ASMB Stock | USD 17.49 0.34 1.98% |
Below is the normalized historical share price chart for Assembly Biosciences extending back to December 17, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Assembly Biosciences stands at 17.49, as last reported on the 5th of January, with the highest price reaching 18.05 and the lowest price hitting 17.21 during the day.
If you're considering investing in Assembly Stock, it is important to understand the factors that can impact its price. Assembly Biosciences appears to be somewhat reliable, given 3 months investment horizon. Assembly Biosciences secures Sharpe Ratio (or Efficiency) of 0.0814, which signifies that the company had a 0.0814% return per unit of risk over the last 3 months. We have found thirty technical indicators for Assembly Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Assembly Biosciences' Mean Deviation of 3.17, risk adjusted performance of 0.0714, and Downside Deviation of 3.55 to double-check if our risk estimates are consistent with your expectations.
At present, Assembly Biosciences' Common Stock Total Equity is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 998.5 M, whereas Total Stockholder Equity is forecasted to decline to about 44.9 M. . As of January 5, 2025, Price To Sales Ratio is expected to decline to 6.87. In addition to that, Price Earnings Ratio is expected to decline to -0.89. Assembly Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 17th of December 2010 | 200 Day MA 15.1126 | 50 Day MA 16.0714 | Beta 0.588 |
Assembly |
Sharpe Ratio = 0.0814
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ASMB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.61 actual daily | 41 59% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Assembly Biosciences is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Assembly Biosciences by adding it to a well-diversified portfolio.
Price Book 4.2753 | Enterprise Value Ebitda 0.4244 | Price Sales 5.1753 | Shares Float 3.8 M | Wall Street Target Price 35.5 |
Assembly Biosciences Main Headline on 3rd of January 2025
Atypical journalists probe Gurmit Singhs speeding scandal, i... by channelnewsasia.com
What happens when a group of neurodivergent individuals get to quiz big names like Gurmit Singh and President Tharman The Assembly brings open conversations to the forefront, in a format that is the first of its kind in Asia.
Assembly Biosciences Valuation on January 3, 2025
It is possible to determine the worth of Assembly Biosciences on a given historical date. On January 3, 2025 Assembly was worth 17.3 at the beginning of the trading date compared to the closed value of 17.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Assembly Biosciences stock. Still, in general, we apply an absolute valuation method to find Assembly Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Assembly Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Assembly Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 15.99 | 17.20 | 15.80 | 17.15 | 46,168 | |
01/03/2025 | 17.30 | 18.05 | 17.21 | 17.49 | 50,270 |
| 17.30 | 18.05 | 17.21 | 17.49 | 0.00 |
| Backtest Assembly Biosciences | | | Assembly Biosciences History | | | Assembly Biosciences Valuation | Previous | Next |
Assembly Biosciences Trading Date Momentum on January 3, 2025
| On January 05 2025 Assembly Biosciences was traded for 17.49 at the closing time. The top price for the day was 18.05 and the lowest listed price was 17.21 . There was no trading activity during the period 0.0. Lack of trading volume on January 5, 2025 did not affect price variability. The overall trading delta against the current closing price is 1.09% . |
Assembly Biosciences Fundamentals Correlations and Trends
By evaluating Assembly Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Assembly Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Assembly financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Assembly Biosciences Stock history
Assembly Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Assembly is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Assembly Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Assembly Biosciences stock prices may prove useful in developing a viable investing in Assembly Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.3 M | 5 M | |
| Net Loss | -83.8 M | -88 M |
Assembly Biosciences Quarterly Net Working Capital |
|
Assembly Biosciences Stock Technical Analysis
Assembly Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Assembly Biosciences Period Price Range
Low | January 5, 2025
| High |
0.00 | 0.00 |
Assembly Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Assembly Biosciences January 5, 2025 Market Strength
Market strength indicators help investors to evaluate how Assembly Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Assembly Biosciences shares will generate the highest return on investment. By undertsting and applying Assembly Biosciences stock market strength indicators, traders can identify Assembly Biosciences entry and exit signals to maximize returns
Assembly Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Assembly Biosciences' price direction in advance. Along with the technical and fundamental analysis of Assembly Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Assembly to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0714 | |||
| Jensen Alpha | 0.3317 | |||
| Total Risk Alpha | 0.2727 | |||
| Sortino Ratio | 0.0927 | |||
| Treynor Ratio | 0.4387 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Assembly Stock analysis
When running Assembly Biosciences' price analysis, check to measure Assembly Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assembly Biosciences is operating at the current time. Most of Assembly Biosciences' value examination focuses on studying past and present price action to predict the probability of Assembly Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assembly Biosciences' price. Additionally, you may evaluate how the addition of Assembly Biosciences to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |